
Acrivon Therapeutics
Biotech company specializing in drug development through early clinical treatment success.
Market cap
$42.8m
Enterprise value
($91m)
Share price
$1.33 ACRV
Authorizing premium user...
Biotech company specializing in drug development through early clinical treatment success.